Inter Pharma

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 03:30:00 15/05/2024 am IST			5-day change	1st Jan Change
6.25 ^THB	-2.34%		-6.72%	+12.85%

14/05	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04	Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024	CI

Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as Director

December 01, 2022 at 03:31 pm IST

Inter Pharma Public Company Limited announced that Mr. Terdkiat Prommool has resigned from the Director of the Company due to his other business engagement, effective from December 1, 2022 onwards.

Latest news about Inter Pharma

Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024	26/04	CI
Inter Pharma Public Company Limited (SET:IP) agreed to acquire 70% stake in Metta Medtech Company Limited from Sittisak Phanitpotchaman for THB 130 million.	05/03	CI
Inter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024	01/03	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	01/03	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12	CI
Inter Pharma Public Company Limited Announces Resignation of Mrs. Nattarin Polpuech as Director, Member of Risk Management Committee and Member of the Executive Committee	26/23/26	CI
Inter Pharma Public Company Limited Announces CFO Changes	26/23/26	CI
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2022, Payable on May 26, 2023	27/23/27	CI
Inter Pharma Public Company Limited Approves Board Changes	28/23/28	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as Director	01/22/01	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/22/10	CI
Inter Pharma Public Company Limited Approves Board and Committee Changes	10/22/10	CI
Inter Pharma Public Company Limited announced that it has received THB 1.04314 billion in funding from Innobic LL Holding Company Limited	10/22/10	CI
Inter Pharma Public Company Limited Approves Election of Directors	20/22/20	CI
Inter Pharma Public Company Limited announced that it expects to receive funding from Innobic LL Holding Company Limited	20/22/20	CI
Inter Pharma Public Company Limited Announces Chief Financial Officer Changes	04/22/04	CI
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Inter Pharma Public Company Limited Proposes Omission of Dividend Payment for 2021	25/22/25	CI
Inno Hub Company Limited Enters into Preliminary Memorandum of Understanding with Inter Pharma Public Company Limited	08/21/08	CI

Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Inter Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

6.25

Average target price

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INTER PHARMA	+12.85%	106M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-2.78%	364B
MERCK & CO., INC.	+20.54%	326B
ABBVIE INC.	+5.57%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+11.04%	167B
PFIZER, INC.	+0.27%	161B

Other Pharmaceuticals

Inter Pharma

Equities

IP

TH9474010005

Pharmaceuticals

Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as Director

Latest news about Inter Pharma

Chart Inter Pharma

Company Profile

Income Statement Evolution

Ratings for Inter Pharma

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals